Amena Rahman

873 total citations
17 papers, 723 citations indexed

About

Amena Rahman is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Amena Rahman has authored 17 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Amena Rahman's work include Microtubule and mitosis dynamics (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Amena Rahman is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Amena Rahman collaborates with scholars based in United States, Japan and Switzerland. Amena Rahman's co-authors include Lawrence S.B. Goldstein, Dara Spatz Friedman, Adeela Kamal, Elizabeth A. Roberts, Kazuhiro Takamizawa, Paul Shabram, Murali Ramachandra, G W Demers, Duane E. Johnson and Chun‐hong Xia and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Nature Biotechnology.

In The Last Decade

Amena Rahman

17 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amena Rahman United States 14 400 216 193 140 105 17 723
Martijn J. W. E. Rabelink Netherlands 16 599 1.5× 384 1.8× 60 0.3× 193 1.4× 73 0.7× 30 855
Ken‐ichi Yano Japan 16 911 2.3× 127 0.6× 79 0.4× 224 1.6× 191 1.8× 24 1.2k
Xian‐Yang Zhang United States 17 1.1k 2.7× 424 2.0× 57 0.3× 139 1.0× 32 0.3× 25 1.4k
J A Wyke United Kingdom 22 858 2.1× 370 1.7× 314 1.6× 198 1.4× 27 0.3× 51 1.3k
Steven Rodems United States 11 549 1.4× 90 0.4× 45 0.2× 114 0.8× 36 0.3× 20 836
Stephen A. Chappell United States 17 1.4k 3.6× 258 1.2× 62 0.3× 134 1.0× 41 0.4× 19 1.7k
Ángel Cid-Arregui Germany 20 427 1.1× 183 0.8× 102 0.5× 432 3.1× 23 0.2× 44 1.1k
Maximilian Krause Norway 5 971 2.4× 176 0.8× 111 0.6× 77 0.6× 22 0.2× 8 1.2k
Georg Feger United States 14 704 1.8× 165 0.8× 158 0.8× 39 0.3× 18 0.2× 16 1.2k
Roger G. E. Palfree Canada 20 652 1.6× 102 0.5× 107 0.6× 113 0.8× 38 0.4× 34 1.3k

Countries citing papers authored by Amena Rahman

Since Specialization
Citations

This map shows the geographic impact of Amena Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amena Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amena Rahman more than expected).

Fields of papers citing papers by Amena Rahman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amena Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amena Rahman. The network helps show where Amena Rahman may publish in the future.

Co-authorship network of co-authors of Amena Rahman

This figure shows the co-authorship network connecting the top 25 collaborators of Amena Rahman. A scholar is included among the top collaborators of Amena Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amena Rahman. Amena Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Papadopoulou, Athina, Stefanie von Felten, Amena Rahman, et al.. (2012). Evolution of MS lesions to black holes under DNA vaccine treatment. Journal of Neurology. 259(7). 1375–1382. 15 indexed citations
2.
Qiu, Zhihua, Yong Ying, Michael Fox, et al.. (2010). A novel homogeneous Biotin–digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum. Journal of Immunological Methods. 362(1-2). 101–111. 21 indexed citations
3.
Rahman, Amena, et al.. (2008). In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Vaccine. 26(17). 2073–2080. 44 indexed citations
4.
Yokoyama, Kazuo, et al.. (2007). Activity of anti‐Porphyromonas gingivalis egg yolk antibody against gingipains in vitro. Oral Microbiology and Immunology. 22(5). 352–355. 18 indexed citations
5.
Sauter, Sybille L., et al.. (2005). Non-Replicating Viral Vector-Based AIDS Vaccines: Interplay Between Viral Vectors and the Immune System. Current HIV Research. 3(2). 157–181. 12 indexed citations
6.
Tsai, Van, Duane E. Johnson, Amena Rahman, et al.. (2004). Impact of Human Neutralizing Antibodies on Antitumor Efficacy of an Oncolytic Adenovirus in a Murine Model. Clinical Cancer Research. 10(21). 7199–7206. 69 indexed citations
7.
Rahman, Amena, et al.. (2003). A role of xylanase, α-L-arabinofuranosidase, and xylosidase in xylan degradation. Canadian Journal of Microbiology. 49(1). 58–64. 55 indexed citations
8.
Rahman, Amena, Koji Kato, S. Kawai, & Kazuhiro Takamizawa. (2003). Substrate specificity of the α-l-arabinofuranosidase from Rhizomucor pusillus HHT-1. Carbohydrate Research. 338(14). 1469–1476. 21 indexed citations
9.
Ramachandra, Murali, Isabella Atencio, Amena Rahman, et al.. (2002). Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis.. PubMed. 62(21). 6045–51. 34 indexed citations
10.
Rahman, Amena, Van Tsai, Shu Fen Wen, et al.. (2001). Specific Depletion of Human Anti-adenovirus Antibodies Facilitates Transduction in an in Vivo Model for Systemic Gene Therapy. Molecular Therapy. 3(5). 768–778. 41 indexed citations
11.
Ramachandra, Murali, Amena Rahman, Aihua Zou, et al.. (2001). Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy. Nature Biotechnology. 19(11). 1035–1041. 113 indexed citations
12.
Rahman, Amena, et al.. (2001). Physicochemical properties of a novel α-L-arabinofuranosidase from <i>Rhizomucor pusillus</i> HHT-1. Canadian Journal of Microbiology. 47(8). 767–772. 2 indexed citations
13.
Rahman, Amena, Adeela Kamal, Elizabeth A. Roberts, & Lawrence S.B. Goldstein. (1999). Defective Kinesin Heavy Chain Behavior in Mouse Kinesin Light Chain Mutants. The Journal of Cell Biology. 146(6). 1277–1288. 88 indexed citations
14.
Rahman, Amena, Dara Spatz Friedman, & Lawrence S.B. Goldstein. (1998). Two Kinesin Light Chain Genes in Mice. Journal of Biological Chemistry. 273(25). 15395–15403. 99 indexed citations
15.
Xia, Chun‐hong, Amena Rahman, Zhaohuai Yang, & Lawrence S.B. Goldstein. (1998). Chromosomal Localization Reveals Three Kinesin Heavy Chain Genes in Mouse. Genomics. 52(2). 209–213. 63 indexed citations
16.
Rahman, Amena, David S. Friedman, & Lawrence S.B. Goldstein. (1998). Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins.. Journal of Biological Chemistry. 273(37). 24280–24280. 2 indexed citations
17.
Rahman, Amena, Ali Esmaili, & Fahri Saatcioglu. (1995). A Unique Thyroid Hormone Response Element in the Human Immunodeficiency Virus Type 1 Long Terminal Repeat That Overlaps the Sp1 Binding Sites. Journal of Biological Chemistry. 270(52). 31059–31064. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026